CooperSurgical v European Distribution Center Motiva (CFI, 4 December 2025)
| Date | 4 December 2025 |
|---|---|
| Court | CFI |
| Division | Brussels (BE) Local Division |
| Type of action | Withdrawal (RoP265) |
| Case number(s) | UPC_CFI_415/2025 |
| Registry reference | UPC_CFI_415/2025 |
| Parties | CooperSurgical, Inc. v. European Distribution Center Motiva BVBA, Establishment Labs S.A. and PulseLavage AB |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
In a decision of 4 December 2025, the Brussels Local Division allowed CooperSurgical to withdraw its infringement action (EP 3 302 292 B1), brought while an EPO opposition was pending, and ordered it to pay the defendants’ costs: EUR 105,757.90 to European Distribution Center Motiva and Establishment Labs, EUR 81,423.33 to PulseLavage. The decision shows the price of suing despite a negative preliminary opinion from the Opposition Division.
Question
Can a patentee that withdraws its action after the Opposition Division revokes the patent obtain an order that each party bear its own costs, on grounds of exceptional circumstances or unnecessary costs?
Decision
No. Suing during opposition proceedings is a fundamental right, which neither the UPCA nor the Rules prohibit, but a claimant that sues despite a negative preliminary opinion takes the risk. The defendants’ costs of defending the claim are not unnecessary (paragraphs 22 to 27). There were no exceptional circumstances: the withdrawal came two weeks after revocation, whereas a cautious claimant would have prepared for that outcome (paragraph 28). A withdrawing claimant is the unsuccessful party (paragraph 30). Costs must be reasonable, proportionate and proven. Assessing ex ante the value in dispute (EUR 4.25 million), the importance of the case, the stage of withdrawal and complexity, the division allowed EUR 100,000 in representation costs for the first two defendants, the EUR 400,000 ceiling applying to full proceedings (paragraphs 31 to 39).
Key points for practice
- Practical point: a patentee suing during an opposition must factor in the risk of bearing the defence costs if the patent is revoked, and withdraw promptly after an adverse decision.
Provisions applied
- Agreement on a Unified Patent Court
- Arts 33(10) and 69
- Rules of Procedure
- Rules 152, 265 and 295(a)
- Case law cited
- Carrier v BITZER Electronics, Court of Appeal, 28 May 2024, Court of Appeal, UPC_CoA_232/2025, Fujifilm v Kodak, Düsseldorf Local Division (UPC_CFI_355/2025 and UPC_CFI_186/2025), OrthoApnea, Brussels Local Division, 25 July 2025
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Unitary patent, Local and central divisions (UPC).
Dhenne Avocats blog: The Transitional Period and the UPC: Coordinating Two Judicial Orders.
Publications by Matthieu Dhenne: Four Questions That Decide a UPC Market Entry, Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantCooperSurgical, Inc.Follow this party
- defendantEuropean Distribution Center Motiva BVBAFollow this party
- defendantEstablishment Labs S.A. and PulseLavage ABFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Withdrawal (RoP265)
- Outcome (Dhenne Avocats summary)
- Le retrait est autorisé et CooperSurgical, partie qui succombe, supporte les frais des défenderesses, fixés à 105 757,90 euros et 81 423,33 euros, sans circonstance exceptionnelle ni frais inutiles.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 302 292 B1mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- OrthoApnea v *** (CFI, 25 July 2025) cited in this record
- Carrier v BITZER Electronics (CoA, 28 May 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 302 292 B1 | Mentioned in the analysis (role not qualified) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.